These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 35586934)
1. Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens. Lim J; Hong J; Jung Y; Ha J; Kim H; Myung H; Song M J Microbiol Biotechnol; 2022 Jun; 32(6):816-823. PubMed ID: 35586934 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria. Zhang S; Chang Y; Zhang Q; Yuan Y; Qi Q; Lu X Microb Cell Fact; 2022 Aug; 21(1):171. PubMed ID: 35999567 [TBL] [Abstract][Full Text] [Related]
3. A Novel Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267 [TBL] [Abstract][Full Text] [Related]
4. Combined effect of SAR-endolysin LysKpV475 with polymyxin B and Gontijo M; Pereira Teles M; Martins Correia H; Pérez Jorge G; Rodrigues Santos Goes IC; Fasabi Flores AJ; Braz M; de Moraes Ceseti L; Zonzini Ramos P; Rosa E Silva I; Pereira Vidigal PM; Kobarg J; Miguez Couñago R; Alvarez-Martinez CE; Pereira C; Freire CSR; Almeida A; Brocchi M Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739436 [TBL] [Abstract][Full Text] [Related]
5. Unveiling the mechanism of bactericidal activity of a cecropin A-fused endolysin LNT113. Cho J; Hong HW; Park K; Myung H; Yoon H Int J Biol Macromol; 2024 Mar; 260(Pt 1):129493. PubMed ID: 38224804 [TBL] [Abstract][Full Text] [Related]
6. Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin. Lim J; Jang J; Myung H; Song M J Microbiol; 2022 Aug; 60(8):859-866. PubMed ID: 35614377 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Three Different Endolysins Effective against Gram-Negative Bacteria. Jeong TH; Hong HW; Kim MS; Song M; Myung H Viruses; 2023 Mar; 15(3):. PubMed ID: 36992387 [TBL] [Abstract][Full Text] [Related]
8. Cloning and expression analysis of fused holin-endolysin from RL bacteriophage; Exhibits broad activity against multi drug resistant pathogens. Basit A; Qadir S; Qureshi S; Rehman SU Enzyme Microb Technol; 2021 Sep; 149():109846. PubMed ID: 34311883 [TBL] [Abstract][Full Text] [Related]
10. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria. Sui B; Wang X; Zhao T; Zhen J; Ren H; Liu W; Zhang X; Zhang C Appl Environ Microbiol; 2023 Jul; 89(7):e0058123. PubMed ID: 37338346 [TBL] [Abstract][Full Text] [Related]
11. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity. Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337 [TBL] [Abstract][Full Text] [Related]
12. Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin. Park W; Park M; Chun J; Hwang J; Kim S; Choi N; Kim SM; Kim S; Jung S; Ko KS; Kweon DH Int J Antimicrob Agents; 2024 Aug; 64(2):107216. PubMed ID: 38795926 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa. Kim S; Lee DW; Jin JS; Kim J J Glob Antimicrob Resist; 2020 Sep; 22():32-39. PubMed ID: 32006750 [TBL] [Abstract][Full Text] [Related]
14. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity. Kim S; Jin JS; Choi YJ; Kim J Viruses; 2020 Nov; 12(11):. PubMed ID: 33238548 [TBL] [Abstract][Full Text] [Related]
15. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region. Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780 [TBL] [Abstract][Full Text] [Related]
16. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity. Yuan Y; Li X; Wang L; Li G; Cong C; Li R; Cui H; Murtaza B; Xu Y Microb Biotechnol; 2021 Mar; 14(2):403-418. PubMed ID: 32519416 [TBL] [Abstract][Full Text] [Related]
17. Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens. Briers Y; Walmagh M; Van Puyenbroeck V; Cornelissen A; Cenens W; Aertsen A; Oliveira H; Azeredo J; Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R mBio; 2014 Jul; 5(4):e01379-14. PubMed ID: 24987094 [TBL] [Abstract][Full Text] [Related]
18. A Lysozyme Murein Hydrolase with Broad-Spectrum Antibacterial Activity from Enterobacter Phage myPSH1140. Ramesh N; Manohar P; Eniyan K; Archana L; Athira S; Loh B; Ma L; Leptihn S Antimicrob Agents Chemother; 2022 Sep; 66(9):e0050622. PubMed ID: 35950843 [TBL] [Abstract][Full Text] [Related]
19. Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant Islam MM; Kim D; Kim K; Park SJ; Akter S; Kim J; Bang S; Kim S; Kim J; Lee JC; Hong CW; Shin M Front Microbiol; 2022; 13():988522. PubMed ID: 36225352 [TBL] [Abstract][Full Text] [Related]